SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Applied Materials
AMAT 334.97+4.8%12:28 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tito L. Nisperos Jr. who wrote (47712)6/7/2001 12:37:52 PM
From: Alan Gallaspy   of 70976
 
I like to keep an eye on Axcelis (former Eaton implant division), as AMAT thinks they can gain market share at their expense. Here is MSDW's take on ACLS. Does anyone have a notion of how well AMAT is penetrating the implant market?

Axcelis (ACLS-$16-SB-V) New Products: Not Just an Implant Co. Anymore J. Deahna/S. Pelayo


ACLS recently introduced a new 300mm resist strip tool. We believe ACLS continues to gain momentum for 300mm strip tools.
Additionally, ACLS announced a joint development agreement with Dow Corning. This could potentially provide a large market for ACLS's photostabilization technology.
ACLS shares are currently trading at 2.2x trailing sales. We continue to believe that ACLS shares are reasonably valued and investor should build position by the Aug "New Products: Not Just an Implant Co. Anymore" timeframe.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext